Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection

Infection. 2012 Jun;40(3):331-4. doi: 10.1007/s15010-011-0196-3. Epub 2011 Oct 18.

Abstract

Introduction: Catheter-related bloodstream infections very often involve the premature removal of long-term intravascular devices (LTID). The antibiotic lock therapy (ALT) represents a conservative approach to the treatment of uncomplicated infections of tunneled LTID when catheter removal is not a feasible option.

Case report: We present here the first reported case of tunneled LTID bloodstream infection due to a multidrug resistant Lactobacillus rhamnosus. The patient, who had large granular lymphocytic leukemia, was successfully treated with systemic tigecycline therapy and lock therapy.

Conclusion: Our results confirm ALT as a valid catheter-salvage strategy for the treatment of CRBSIs in clinically stable patients when catheter removal is not a feasible option, tigecycline appear to be a good option.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy*
  • Catheter-Related Infections / drug therapy*
  • Catheter-Related Infections / microbiology
  • Catheterization, Central Venous / adverse effects
  • Catheters, Indwelling / microbiology
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Gram-Positive Bacterial Infections / drug therapy*
  • Gram-Positive Bacterial Infections / microbiology
  • Humans
  • Lacticaseibacillus rhamnosus / drug effects
  • Lacticaseibacillus rhamnosus / isolation & purification*
  • Microbial Sensitivity Tests
  • Minocycline / analogs & derivatives*
  • Minocycline / therapeutic use
  • Tigecycline
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Tigecycline
  • Minocycline